Research
Hormonal
The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in obesity management is increasing.
Practitioners should be aware of the growing role of GLP-1 RAs in obesity treatment.
StrongSupportsmedium confidence
National trends show increased use of GLP-1 RAs in obesity management.
Why this rating
The claim is based on national trends, indicating a broad data source.
Source
Endobariatrics in the era of glucagon-like peptide-1 receptor agonists: evolving roles, evidence, and integration
Farnoosh Vahedi et al. · Current Opinion in Gastroenterology · 2025
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →